hydroxychloroquine has been researched along with Mastocytosis in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Espinosa, E | 1 |
Valitutti, S | 1 |
Laroche, M | 1 |
Laurent, C | 1 |
Apoil, PA | 1 |
Hermine, O | 1 |
Lavit, M | 1 |
Paul, C | 1 |
Bulai Livideanu, C | 1 |
1 other study available for hydroxychloroquine and Mastocytosis
Article | Year |
---|---|
Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases.
Topics: Humans; Hydroxychloroquine; Inflammation Mediators; Lysosomes; Male; Mast Cells; Mastocytosis; Middl | 2018 |